Compare, Analyse PLETHICO PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
TEVA PHARMA
Dec-13
PLETHICO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3952,961-   
Low Rs312,573-   
Sales per share (Unadj.) Rs604.41,699.6-  
Earnings per share (Unadj.) Rs32.5106.2-  
Cash flow per share (Unadj.) Rs51.3243.6-  
Dividends per share (Unadj.) Rs092.94-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs473.61,888.0-  
Shares outstanding (eoy) m34.08848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.41.6 21.7%   
Avg P/E ratio x6.626.1 25.2%  
P/CF ratio (eoy) x4.211.4 36.5%  
Price / Book Value ratio x0.51.5 30.7%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m7,2622,346,458 0.3%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1,5960-   
Avg. sales/employee Rs ThNM32,067.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,003.2-  
INCOME DATA
Net Sales Rs m20,5981,441,278 1.4%  
Other income Rs m3860-   
Total revenues Rs m20,9841,441,278 1.5%   
Gross profit Rs m2,818394,695 0.7%  
Depreciation Rs m642116,500 0.6%   
Interest Rs m1,59328,309 5.6%   
Profit before tax Rs m969249,886 0.4%   
Minority Interest Rs m01,135 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-164,036 0.0%   
Tax Rs m-138-3,051 4.5%   
Profit after tax Rs m1,10790,036 1.2%  
Gross profit margin %13.727.4 50.0%  
Effective tax rate %-14.3-1.2 1,170.3%   
Net profit margin %5.46.2 86.0%  
BALANCE SHEET DATA
Current assets Rs m18,877973,434 1.9%   
Current liabilities Rs m11,896848,917 1.4%   
Net working cap to sales %33.98.6 392.3%  
Current ratio x1.61.1 138.4%  
Inventory Days Days3691 39.6%  
Debtors Days Days19896 206.3%  
Net fixed assets Rs m9,861470,753 2.1%   
Share capital Rs m3413,548 9.6%   
"Free" reserves Rs m12,3310-   
Net worth Rs m16,1391,600,987 1.0%   
Long term debt Rs m4,706736,958 0.6%   
Total assets Rs m33,1463,293,783 1.0%  
Interest coverage x1.69.8 16.4%   
Debt to equity ratio x0.30.5 63.3%  
Sales to assets ratio x0.60.4 142.0%   
Return on assets %8.13.6 226.7%  
Return on equity %6.95.6 122.0%  
Return on capital %12.34.9 249.2%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,437229,665 1.1%  
From Investments Rs m-6,265-81,380 7.7%  
From Financial Activity Rs m2,490-275,499 -0.9%  
Net Cashflow Rs m-1,337-127,213 1.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare PLETHICO PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare PLETHICO PHARMA With: CIPLA  AJANTA PHARMA  SUVEN LIFESCIENCES  AUROBINDO PHARMA  FDC LTD.  



Today's Market

September Quarter Results, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Wednesday, Indian share markets traded rangebound throughout the day and ended marginally higher. The BSE Sensex closed higher by 95 points to end above 39,000-mark.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS